USPTO serial 99072406
Reviewed by CopyMark Law Group
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jennette W. Psihoules
Jennette W. Psihoules Nixon Peabody LLP799 9th Street, NW, Suite 500Washington, DC 20001United States| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biological tissue, namely, stem cells for scientific and medical research use in the field of cryopreservation, bioengineering, and stem cell science for personalized regenerative medicine; Biochemical reagents for scientific use in the field of cryopreservation, bioengineering, and stem cell science for personalized regenerative medicine; cell growth media for growing cells for scientific use; Cryopreservation kits comprised of cryopreservation media for storing and transferring biological samples, namely, stem cells, for use in scientific research; Preservation kits comprised of chemical preparations for preserving biological samples, namely, stem cells, in the field of cryopreservation, bioengineering, and stem cell science for personalized regenerative medicine; cryopreservation kits for use in scientific research in the fields of bioengineering and stem cell science for the purposes of the cryogenic preservation of stem cells, namely cryopreservation kits consisting primarily of sperm freezing medium, in vitro fertilization medium, sperm freezing canister, cans for holding straws filled with semen, and mixing tubes ; Cryopreservation kits for use in scientific research for storing and transferring biological samples, namely, cryopreservation kits comprised of cryopreservation media and reagents for scientific use and research use | ACTIVE | — |
| 005 | Diagnostic preparations and reagents for medical use, namely, for detecting, characterizing, and monitoring stem cells for use in regenerative medicine; stem cell collection and preservation kits for personalized regenerative medicine comprised primarily of swabs for medical purposes and also including plastic bags for transmitting and storing medical specimens; personalized stem cell-based topical preparations for hair care and skin care for regenerative medicine purposes, namely creams, sprays, balms, ointments, and injectable solutions, gels and serums specifically for hair care and skin care for regenerative medicine purposes | ACTIVE | — |
| 010 | Non-invasive medical instruments for collecting stem cells; Biological sample collection kits for collecting stem cells for medical and diagnostic use, namely, blood collection kits for the purposes of isolating stem cells comprised of blood collection bag, holder for medical sample tubes and vials, and medical sample tubes and vials | ACTIVE | — |
| 040 | Cryopreservation services, namely, cryogenic storage of biological tissue in the field of personalized regenerative medicine | ACTIVE | — |
| 042 | Consultation, research and development in genetic science and biotechnology in the field of cryopreservation, bioengineering, and stem cell science for personalized regenerative medicine; software as a service (SaaS) services featuring software for remote monitoring, managing, controlling, and securing of clinical, medical and laboratory equipment and cellular cryopreservation data; laboratory and scientific research services in the field of specimen preservation by freezing and thawing, namely, cryogenics, cryopreservation and shipping cryopreserved cell therapy samples to medical clinics for thawing and administering to patients | ACTIVE | — |
| 044 | Stem cell banking and preservation services | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 28, 2026 | GNS1 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | — |
| Aug 28, 2026 | GNCF | CONTINUATION OF FINAL REFUSAL E-MAILED | — |
| Aug 28, 2026 | CNCF | ACTION CONTINUING A FINAL - COMPLETED | — |
| Jul 6, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 6, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 6, 2026 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Apr 6, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 6, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 6, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 25, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 25, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 25, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 7, 2025 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Nov 7, 2025 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Aug 20, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 20, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 20, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 8, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 7, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 7, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 7, 2025 | NWAP | NEW APPLICATION ENTERED | — |